title: Antibiotics for the treatment of hepatic encephalopathy.
abstract: The treatment of hepatic encephalopathy (HE) is complex and therapeutic regimens vary according to the acuity of presentation and the goals of therapy. Most treatments for HE rely on manipulating the intestinal milieu and therefore antibiotics that act on the gut form a key treatment strategy. Prominent antibiotics studied in HE are neomycin, metronidazole, vancomycin and rifaximin. For the management of the acute episode, all antibiotics have been tested. However the limited numbers studied, adverse effects (neomycin oto- and nephrotoxicity, metronidazole neurotoxicity) and potential for resistance emergence (vancomycin-resistant enterococcus) has limited the use of most antibiotics, apart from rifaximin which has the greatest evidence base. Rifaximin has also demonstrated, in conjunction with lactulose, to prevent overt HE recurrence in a multi-center, randomized trial. Despite its cost in the US, rifaximin may prove cost-saving by preventing hospitalizations for overt HE. In minimal/covert HE, rifaximin is the only systematically studied antibiotic. Rifaximin showed improvement in cognition, inflammation, quality-of-life and driving simulator performance but cost-analysis does not favor its use at the current time. Antibiotics, especially rifaximin, have a definite role in the management across the spectrum of HE.
authors: Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, 1201 Broad Rock Boulevard, Richmond, VA, USA.
authors: Kavish R
authors: KR
authors: Patidar
authors: Jasmohan S
authors: JS
authors: Bajaj
mesh_terms: D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000188:drug therapy* / Q000191:economics / Q000209:etiology; D006801:Humans; D007239:Infections / Q000150:complications
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents
references: Transplant Proc. 2010 Dec;42(10):4543-7
references: 21168733
references: Am J Physiol Gastrointest Liver Physiol. 2012 Sep 15;303(6):G675-85
references: 22821944
references: Dig Dis Sci. 2007 Mar;52(3):737-41
references: 17245628
references: Gut. 1982 Jan;23(1):1-7
references: 7035298
references: Chemotherapy. 2005;51 Suppl 1:67-72
references: 15855749
references: J Hepatol. 2011 Apr;54(4):640-9
references: 21163546
references: J Clin Gastroenterol. 2012 Feb;46(2):168-71
references: 22011586
references: Gastroenterology. 2011 Feb;140(2):478-487.e1
references: 20849805
references: Yonsei Med J. 2005 Jun 30;46(3):399-407
references: 15988813
references: N Engl J Med. 2010 Mar 25;362(12):1071-81
references: 20335583
references: Am J Dig Dis. 1978 May;23(5):398-406
references: 354373
references: J Chemother. 2002 Jun;14(3):290-5
references: 12120885
references: Aliment Pharmacol Ther. 2010 Mar;31(5):537-47
references: 20002027
references: J Hepatol. 2003 Jan;38(1):51-8
references: 12480560
references: Curr Med Res Opin. 1993;13(2):109-18
references: 8325041
references: Am J Gastroenterol. 2001 Jul;96(7):1968-76
references: 11467622
references: Hepatogastroenterology. 1992 Dec;39(6):542-5
references: 1483668
references: Drugs Exp Clin Res. 1985;11(6):387-92
references: 3836135
references: Scand J Gastroenterol. 1987 Jan;22(1):117-23
references: 3563404
references: Aliment Pharmacol Ther. 2007 Oct 15;26(8):1147-61
references: 17894657
references: Hepatology. 2010 Oct;52(4):1484-8
references: 20814894
references: Dig Dis Sci. 1981 Jun;26(6):498-506
references: 7016484
references: Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):515-25
references: 20703237
references: Hepatology. 2012 Dec;56(6):2328-35
references: 22806618
references: ACP J Club. 2008 Nov 18;149(5):11
references: 19014178
references: Transplant Proc. 2007 Dec;39(10):3204-6
references: 18089354
references: Am J Gastroenterol. 2010 Jun;105(6):1374-81
references: 20125128
references: Am J Gastroenterol. 2011 Feb;106(2):307-16
references: 21157444
references: Aliment Pharmacol Ther. 2007 Feb;25 Suppl 1:3-9
references: 17295846
references: Gastroenterology. 1977 Apr;72(4 Pt 1):573-83
references: 14049
references: Aliment Pharmacol Ther. 2011 Oct;34(8):853-61
references: 21848797
references: Clin Gastroenterol Hepatol. 2012 Sep;10(9):1034-41.e1
references: 22642955
references: Hepatology. 2012 May;55(5):1551-61
references: 22183941
references: Hepatology. 2009 Dec;50(6):2022-33
references: 19885876
references: J Hepatol. 2010 Sep;53(3):580-2
references: 20561708
references: Int J Hepatol. 2012;2012:480309
references: 23133760
references: Hepatology. 2012 Apr;55(4):1164-71
references: 22135042
references: Gut. 1990 Jun;31(6):702-6
references: 2199349
references: Clin Gastroenterol Hepatol. 2012 Jul;10(7):815-8
references: 22391344